Increasing PrEP Among African Americans in Louisville KY

HIV/AIDS PREVENTION Clinical Trial

Official title:

Increasing Pre-exposure Prophylaxis Among High-Risk African Americans in Louisville KY

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03559595
• Other study ID #: 18.0020
• Status: Completed
• Phase: N/A
• Start date: June 4, 2018
• Est. completion date: December 31, 2020

Study information

• Verified date: March 2021
• Source: University of Louisville
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates the effectiveness of a multifaceted strategy to increase pre-exposure prophylaxis (PrEP; a medication regimen to reduce HIV risk) uptake among high risk African Americans in Louisville, KY. We will do this by 1) implementing a media campaign to raise awareness about PrEP, 2) providing PrEP education to medical personnel who can prescribe PrEP, and 3) partnering with AIDS service organizations to improve outreach and linkage to PrEP services.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 205
• Est. completion date: December 31, 2020
• Est. primary completion date: December 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 29 Years

Eligibility

Inclusion Criteria:

• Between ages 18-29 years old

• Self-identifies as African American or Black

• Resident of Louisville, KY

• Member of a priority group for PrEP HIV prevention (Men who have sex with men, people who inject drugs, trans women, high risk heterosexuals, people in serodiscordant relationships).

• Not diagnosed with HIV

Exclusion Criteria:

• Older than 29 and younger than 18 years old

• Does not identify as African American or Black

• Does not reside in Louisville, KY

• Not a member of a priority group

• Diagnosed with HIV

Related Conditions & MeSH terms

• Acquired Immunodeficiency Syndrome
• HIV Infections
• HIV/AIDS PREVENTION

Intervention

Behavioral:
• Project Prevent
The Project Prevent intervention entails 1) a media campaign to raise PrEP awareness, 2) geographically targeted education initiatives with medical personnel to increase access to consumers, and 3) programming with AIDS service organizations to improve service delivery around PrEP.

Locations

Country	Name	City	State
United States	University of Louisville	Louisville	Kentucky

Sponsors (1)

Lead Sponsor	Collaborator
University of Louisville

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PrEP uptake	Reported use of PrEP	12 months
Secondary	PrEP intentions	Intention to use PrEP	12 months
Secondary	PrEP prescription	Prescription of PrEP to eligible individuals by medical personnel	12 months